Author:
Ravipati Srinivasarao,Baldwin David R.,Barr Helen L.,Fogarty Andrew W.,Barrett David A.
Funder
Nottingham University Hospitals’ Charity
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference40 articles.
1. Brites, P., Waterham, H. R., & Wanders, R. J. A. (2004). Functions and biosynthesis of plasmalogens in health and disease. Biochimica et Biophysica Acta, 1636, 219–231.
2. Cedres, S., Nunez, I., Longo, M., Martinez, P., Checa, E., Torrejon, D., & Felip, E. (2011). Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLS). Clinical Lung Cancer, 12, 172–179.
3. Chee, J., Naran, A., Misso, N. L., Thompson, P. J., & Bhoola, K. D. (2008). Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer. The Journal of Biological Chemistry, 389, 1225–1233.
4. Cheng, L., Alexander, R. E., MacLennan, G. T., Cummings, O. W., Montironi, R., Lopez-Beltran, A., et al. (2012). Molecular pathology of lung cancer: Key to personalized medicine. Modern Pathology, 25, 347–369.
5. de Angelis, R., Sant, M., Coleman, M. P., Francisci, S., Baili, P., et al. (2014). Cancer survival in Europe 1999-2007 by country and age: Results of EUROCARE-5—a population-based study. Lancet Oncology, 15, 23–34.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献